T1	CHEM 14 29	dexmedetomidina
#1	AnnotatorNotes T1	C0113293; dexmedetomidine; Organic Chemical · Pharmacologic Substance
T2	ANAT 52 64	intracraneal
#2	AnnotatorNotes T2	C0524466; Intracranial; Body Location or Region
T3	DISO 82 110	lesión encefálica traumatica
#3	AnnotatorNotes T3	C0018674; Craniocerebral Trauma; Injury or Poisoning | C0876926; Traumatic Brain Injury; Injury or Poisoning
T4	CHEM 121 136	dexmedetomidina
#4	AnnotatorNotes T4	C0113293; dexmedetomidine; Organic Chemical · Pharmacologic Substance
T5	CHEM 141 174	agonista adrenérgico selectivo α2
#5	AnnotatorNotes T5	C2267005; Central alpha-2 Adrenergic Agonist [EPC]; Pharmacologic Substance (?)
T6	PROC 212 225	sedoanalgesia
#6	AnnotatorNotes T6	C0002905; Anesthesia and Analgesia; Therapeutic or Preventive Procedure
T7	PROC 333 352	sedación consciente
#7	AnnotatorNotes T7	C0079159; Conscious Sedation; Therapeutic or Preventive Procedure
T8	DISO 383 405	depresión respiratoria
#8	AnnotatorNotes T8	C0235063; Respiratory Depression; Pathologic Function
T9	CHEM 444 459	dexmedetomidina
#9	AnnotatorNotes T9	C0113293; dexmedetomidine; Organic Chemical · Pharmacologic Substance
T10	CHEM 470 482	agonista α28
T11	ANAT 506 518	intracraneal
#10	AnnotatorNotes T11	C0524466; Intracranial; Body Location or Region
T12	ANAT 558 568	cerebrales
#11	AnnotatorNotes T12	C0242202; Cerebrum; Body Part, Organ, or Organ Component | C1269537; Entire brain; Body Part, Organ, or Organ Component | C1280654; Entire cerebrum; Body Part, Organ, or Organ Component
T13	DISO 598 621	trauma craneoencefálico
#12	AnnotatorNotes T13	C0018674; Craniocerebral Trauma; Injury or Poisoning
T14	PROC 651 670	Estudio prospectivo
#13	AnnotatorNotes T14	C0033522; Prospective Studies; Research Activity
T15	DISO 692 720	lesión encefálica traumática
#14	AnnotatorNotes T15	C0018674; Craniocerebral Trauma; Injury or Poisoning | C0876926; Traumatic Brain Injury; Injury or Poisoning
T16	PROC 728 746	Glasgow Coma Scale
#15	AnnotatorNotes T16	C0278349; Glasgow coma testing and evaluation; Laboratory Procedure
T17	PROC 752 762	ingresados
#16	AnnotatorNotes T17	C0021629; Institutionalization; Health Care Activity | C0184666; Hospital admission; Health Care Activity
T18	PROC 865 868	PIC
#17	AnnotatorNotes T18	C0394279; Procedure for monitoring intracranial pressure; Therapeutic or Preventive Procedure
T19	PROC 822 863	monitorización de la presión intracraneal
#18	AnnotatorNotes T19	C0394279; Procedure for monitoring intracranial pressure; Therapeutic or Preventive Procedure
T20	PROC 926 930	SjO2
T21	PROC 872 906	monitorización de saturación de O2
#19	AnnotatorNotes T21	C4481686; O2 saturation in blood; Laboratory Procedure (?)
T22	ANAT 911 924	bulbo yugular
T23	PROC 948 981	perfusión intravenosa de la droga
#20	AnnotatorNotes T23	C0392877; infusion of drug; Therapeutic or Preventive Procedure + C0021440; Intravenous infusion procedures; Therapeutic or Preventive Procedure
T24	CHEM 976 981	droga
#21	AnnotatorNotes T24	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T25	ANAT 1249 1257	arterial
#22	AnnotatorNotes T25	C0003842; Arteries; Body Part, Organ, or Organ Component | C1285085; Entire artery; Body Part, Organ, or Organ Component
T26	PROC 1370 1373	PPC
#23	AnnotatorNotes T26	C0513027; Monitor cerebral perfusion pressure; Therapeutic or Preventive Procedure (?)
T27	CHEM 1073 1081	sedantes
#24	AnnotatorNotes T27	C0036557; Sedatives; Pharmacologic Substance
T28	CHEM 1084 1095	analgésicos
#25	AnnotatorNotes T28	C0002771; Analgesics; Organic Chemical · Pharmacologic Substance · Hazardous or Poisonous Substance
T29	DISO 1142 1167	hipertensión intracraneal
#26	AnnotatorNotes T29	C0151740; Intracranial Hypertension; Finding
T30	PROC 1224 1238	valores de PIC
#27	AnnotatorNotes T30	C0394279; Procedure for monitoring intracranial pressure; Therapeutic or Preventive Procedure
T31	PROC 1241 1263	presión arterial media
#28	AnnotatorNotes T31	C0513528; Monitor mean arterial pressure; Health Care Activity (?)
T32	PROC 1265 1268	PAM
#29	AnnotatorNotes T32	C0513528; Monitor mean arterial pressure; Health Care Activity (?)
T33	CHEM 1293 1298	droga
#30	AnnotatorNotes T33	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T34	PROC 1499 1518	frecuencia cardíaca
#31	AnnotatorNotes T34	C2197023; examination of heart rate; Health Care Activity
T35	PROC 1339 1368	presión de perfusión cerebral
#32	AnnotatorNotes T35	C0513027; Monitor cerebral perfusion pressure; Therapeutic or Preventive Procedure (?)
T36	ANAT 1646 1656	cerebrales
#33	AnnotatorNotes T36	C0242202; Cerebrum; Body Part, Organ, or Organ Component | C1269537; Entire brain; Body Part, Organ, or Organ Component | C1280654; Entire cerebrum; Body Part, Organ, or Organ Component
T37	CHEM 1713 1728	dexmedetomidina
#34	AnnotatorNotes T37	C0113293; dexmedetomidine; Organic Chemical · Pharmacologic Substance
T38	ANAT 1805 1817	intracraneal
#35	AnnotatorNotes T38	C0524466; Intracranial; Body Location or Region
T39	ANAT 1837 1846	sanguíneo
#36	AnnotatorNotes T39	C0005767; Blood; Body Substance
T40	ANAT 1847 1855	cerebral
#37	AnnotatorNotes T40	C0242202; Cerebrum; Body Part, Organ, or Organ Component | C1269537; Entire brain; Body Part, Organ, or Organ Component | C1280654; Entire cerebrum; Body Part, Organ, or Organ Component
T41	DISO 1891 1914	trauma craneoencefálico
#38	AnnotatorNotes T41	C0018674; Craniocerebral Trauma; Injury or Poisoning
T42	ANAT 89 99	encefálica
#39	AnnotatorNotes T42	C0006104; Brain; Body Part, Organ, or Organ Component | C1269537; Entire brain; Body Part, Organ, or Organ Component
T43	PROC 354 368	simpaticolisis
#40	AnnotatorNotes T43	C2609163; Sympatholysis; Therapeutic or Preventive Procedure
T44	ANAT 605 621	craneoencefálico
#41	AnnotatorNotes T44	C5381840; Craniocerebral; Body Location or Region
T45	ANAT 699 709	encefálica
#42	AnnotatorNotes T45	C0006104; Brain; Body Part, Organ, or Organ Component | C1269537; Entire brain; Body Part, Organ, or Organ Component
T46	ANAT 851 863	intracraneal
#43	AnnotatorNotes T46	C0524466; Intracranial; Body Location or Region
T47	CHEM 904 906	O2
#44	AnnotatorNotes T47	C0030054; oxygen; Biologically Active Substance · Element, Ion, or Isotope · Pharmacologic Substance
T48	ANAT 1155 1167	intracraneal
#45	AnnotatorNotes T48	C0524466; Intracranial; Body Location or Region
T49	PROC 1278 1298	infusión de la droga
#46	AnnotatorNotes T49	C0392877; infusion of drug; Therapeutic or Preventive Procedure + C0021440; Intravenous infusion procedures; Therapeutic or Preventive Procedure
T50	ANAT 1360 1368	cerebral
#47	AnnotatorNotes T50	C0242202; Cerebrum; Body Part, Organ, or Organ Component | C1269537; Entire brain; Body Part, Organ, or Organ Component | C1280654; Entire cerebrum; Body Part, Organ, or Organ Component
T51	ANAT 1510 1518	cardíaca
#48	AnnotatorNotes T51	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T52	PROC 1520 1522	FC
#49	AnnotatorNotes T52	C2197023; examination of heart rate; Health Care Activity
T53	ANAT 1898 1914	craneoencefálico
#50	AnnotatorNotes T53	C5381840; Craniocerebral; Body Location or Region
T54	DISO 1922 1926	TECG
T55	PHYS 39 51	hemodinámica
#51	AnnotatorNotes T55	C0019010; Hemodynamics; Organ or Tissue Function
T56	LIVB 68 77	pacientes
#52	AnnotatorNotes T56	C0030705; Patients; Patient or Disabled Group
T57	LIVB 233 251	pacientes críticos
#53	AnnotatorNotes T57	C0030705; Patients; Patient or Disabled Group + C0815272; critical population; Population Group
T58	Neg_cue 371 382	ausencia de
T59	PHYS 493 505	hemodinámica
#54	AnnotatorNotes T59	C0019010; Hemodynamics; Organ or Tissue Function
T60	LIVB 584 593	pacientes
#55	AnnotatorNotes T60	C0030705; Patients; Patient or Disabled Group
T61	LIVB 678 687	pacientes
#56	AnnotatorNotes T61	C0030705; Patients; Patient or Disabled Group
T64	Route 958 969	intravenosa
#57	AnnotatorNotes T64	C1522726; Intravenous Route of Drug Administration; Functional Concept
T65	Duration 990 997	3 horas
T66	Dose 1021 1041	0.2, 0.4 y 0.7 ug/kg
T68	LIVB 1128 1137	pacientes
#58	AnnotatorNotes T68	C0030705; Patients; Patient or Disabled Group
T69	Neg_cue 1138 1141	sin
T71	Route 1278 1286	infusión
#59	AnnotatorNotes T71	C1621368; Intravenous Drip Route of Administration; Functional Concept
T72	Route 1350 1359	perfusión
#60	AnnotatorNotes T72	C1621368; Intravenous Drip Route of Administration; Functional Concept
T77	PHYS 1792 1804	hemodinámica
#61	AnnotatorNotes T77	C0019010; Hemodynamics; Organ or Tissue Function
T79	PHYS 1825 1836	metabolismo
#62	AnnotatorNotes T79	C0025519; Metabolism; Organism Function
T80	LIVB 1859 1868	pacientes
#63	AnnotatorNotes T80	C0030705; Patients; Patient or Disabled Group
T81	PHYS 342 352	consciente
#64	AnnotatorNotes T81	C0229994; Conscious mind; Mental Process | C0234421; Conscious; Mental Process
T82	PHYS 393 405	respiratoria
#65	AnnotatorNotes T82	C0035203; Respiration; Physiologic Function
T83	PHYS 1241 1257	presión arterial
#66	AnnotatorNotes T83	C0005823; Blood Pressure; Organism Function
T84	PHYS 843 863	presión intracraneal
#67	AnnotatorNotes T84	C0021880; Intracranial Pressure; Organ or Tissue Function
T62	PROC 1002 1019	dosis progresivas
#68	AnnotatorNotes T62	C1707810; Dose Increased; Therapeutic or Preventive Procedure
T63	Frequency 1041 1043	/h
T67	PHYS 542 557	hemometabólicos
A1	Assertion T8 Negated
A2	Assertion T29 Negated
T70	Neg_cue 1570 1572	No
T73	CONC 1585 1596	diferencias
A3	Assertion T73 Negated
#69	AnnotatorNotes T73	C1705241; Delta (difference); Quantitative Concept
R1	Negation Arg1:T70 Arg2:T73	
T74	CONC 1187 1198	diferencias
A4	Assertion T74 Negated
#70	AnnotatorNotes T74	C1705241; Delta (difference); Quantitative Concept
T75	Neg_cue 1169 1171	No
R2	Negation Arg1:T75 Arg2:T74	
R3	Negation Arg1:T69 Arg2:T29	
T76	Neg_cue 1741 1743	no
T78	Observation 1758 1817	alteraciones significativas de la hemodinámica intracraneal
A5	Assertion T78 Negated
R4	Negation Arg1:T76 Arg2:T78	
T85	Observation 1758 1770;1821 1855	alteraciones del metabolismo sanguíneo cerebral
T86	Neg_cue 1818 1820	ni
R5	Negation Arg1:T86 Arg2:T85	
T87	PROC 1053 1063	suspensión
#71	AnnotatorNotes T87	C0850893; stop medication; Therapeutic or Preventive Procedure
R6	Used_for Arg1:T27 Arg2:T87	
R7	Used_for Arg1:T28 Arg2:T87	
R8	Before Arg1:T87 Arg2:T23	
T88	Observation 0 7	Efectos
#72	AnnotatorNotes T88	C1518681; Outcome of Therapy; Finding (?)
R9	Experiences Arg1:T56 Arg2:T3	
R10	Location_of Arg1:T42 Arg2:T3	
R11	Experiences Arg1:T56 Arg2:T55	
R12	Location_of Arg1:T2 Arg2:T55	
R13	Experiences Arg1:T56 Arg2:T88	
R14	Causes Arg1:T1 Arg2:T88	
R15	Experiences Arg1:T56 Arg2:T1	
T89	Quantifier_or_Qualifier 111 116	grave
#73	AnnotatorNotes T89	C1547227; Severe - Severity of Illness Code; Intellectual Product
R16	Has_Quantifier_or_Qualifier Arg1:T3 Arg2:T89	
R17	Experiences Arg1:T57 Arg2:T6	
R18	Experiences Arg1:T57 Arg2:T4	
R19	Experiences Arg1:T57 Arg2:T5	
T90	Observation 261 268	efectos
#74	AnnotatorNotes T90	C1518681; Outcome of Therapy; Finding (?)
R20	Experiences Arg1:T57 Arg2:T90	
R21	Experiences Arg1:T57 Arg2:T7	
R22	Experiences Arg1:T57 Arg2:T81	
R23	Experiences Arg1:T57 Arg2:T43	
R24	Experiences Arg1:T57 Arg2:T8	
R25	Experiences Arg1:T57 Arg2:T82	
R27	Negation Arg1:T58 Arg2:T8	
T91	Observation 431 437	efecto
#75	AnnotatorNotes T91	C1518681; Outcome of Therapy; Finding (?)
R28	Location_of Arg1:T11 Arg2:T59	
R29	Location_of Arg1:T12 Arg2:T67	
R30	Causes Arg1:T9 Arg2:T91	
R31	Causes Arg1:T10 Arg2:T91	
T92	Quantifier_or_Qualifier 622 627	grave
#76	AnnotatorNotes T92	C1547227; Severe - Severity of Illness Code; Intellectual Product
R32	Has_Quantifier_or_Qualifier Arg1:T13 Arg2:T92	
R33	Location_of Arg1:T44 Arg2:T13	
R34	Experiences Arg1:T60 Arg2:T13	
R35	Experiences Arg1:T60 Arg2:T91	
R36	Experiences Arg1:T60 Arg2:T9	
R37	Experiences Arg1:T60 Arg2:T10	
R38	Experiences Arg1:T60 Arg2:T59	
R39	Experiences Arg1:T60 Arg2:T67	
R45	Location_of Arg1:T45 Arg2:T15	
T93	Quantifier_or_Qualifier 721 726	grave
#77	AnnotatorNotes T93	C1547227; Severe - Severity of Illness Code; Intellectual Product
R46	Has_Quantifier_or_Qualifier Arg1:T15 Arg2:T93	
T94	Result_or_Value 747 750	≤ 8
R47	Has_Result_or_Value Arg1:T16 Arg2:T94	
R48	Experiences Arg1:T61 Arg2:T15	
R49	Experiences Arg1:T61 Arg2:T16	
R50	Experiences Arg1:T61 Arg2:T17	
R51	Location_of Arg1:T46 Arg2:T84	
R52	Location_of Arg1:T46 Arg2:T18	
R53	Location_of Arg1:T46 Arg2:T19	
R54	Experiences Arg1:T61 Arg2:T19	
R55	Experiences Arg1:T61 Arg2:T18	
R56	Experiences Arg1:T61 Arg2:T21	
R57	Location_of Arg1:T22 Arg2:T20	
R58	Location_of Arg1:T22 Arg2:T21	
R59	Has_Route_or_Mode Arg1:T24 Arg2:T64	
R60	Used_for Arg1:T24 Arg2:T23	
R61	Has_Duration_or_Interval Arg1:T24 Arg2:T65	
R62	Used_for Arg1:T24 Arg2:T62	
R63	Has_Dose_or_Strength Arg1:T24 Arg2:T66	
R64	Has_Frequency Arg1:T24 Arg2:T63	
R65	Location_of Arg1:T48 Arg2:T29	
R66	Experiences Arg1:T68 Arg2:T29	
T95	Quantifier_or_Qualifier 1199 1213	significativas
A6	Assertion T95 Negated
#78	AnnotatorNotes T95	C0750502; Significant; Idea or Concept
R67	Has_Quantifier_or_Qualifier Arg1:T74 Arg2:T95	
R68	Location_of Arg1:T25 Arg2:T32	
R69	Location_of Arg1:T25 Arg2:T83	
R70	Location_of Arg1:T25 Arg2:T31	
R71	After Arg1:T31 Arg2:T49	
R73	After Arg1:T32 Arg2:T49	
R74	After Arg1:T30 Arg2:T49	
R75	Used_for Arg1:T33 Arg2:T49	
R76	Has_Route_or_Mode Arg1:T33 Arg2:T71	
T96	CONC 1319 1334	valores basales
#79	AnnotatorNotes T96	C1442488; Baseline; Quantitative Concept
R77	Location_of Arg1:T50 Arg2:T26	
R78	Location_of Arg1:T50 Arg2:T35	
R79	Location_of Arg1:T51 Arg2:T52	
R80	Location_of Arg1:T51 Arg2:T34	
T97	Observation 1470 1478;1493 1518	descenso de la frecuencia cardíaca
R81	Location_of Arg1:T51 Arg2:T97	
T98	Observation 1470 1478;1493 1498;1520 1522	descenso de la FC
T99	CONC 1553 1568	valores basales
#80	AnnotatorNotes T99	C1442488; Baseline; Quantitative Concept
T100	CONC 531 568	parámetros hemometabólicos cerebrales
T101	CONC 1619 1656	parámetros hemometabólicos cerebrales
A7	Assertion T85 Negated
R82	Location_of Arg1:T38 Arg2:T78	
R83	Location_of Arg1:T40 Arg2:T85	
R84	Location_of Arg1:T40 Arg2:T79	
R85	Location_of Arg1:T39 Arg2:T85	
R86	Location_of Arg1:T39 Arg2:T79	
R87	Location_of Arg1:T38 Arg2:T77	
R88	Experiences Arg1:T80 Arg2:T37	
R89	Experiences Arg1:T80 Arg2:T78	
R90	Experiences Arg1:T80 Arg2:T85	
R91	Experiences Arg1:T80 Arg2:T41	
R92	Experiences Arg1:T80 Arg2:T54	
R93	Location_of Arg1:T53 Arg2:T41	
R94	Location_of Arg1:T53 Arg2:T54	
T102	PROC 1658 1662	SjO2
T103	CONC 1665 1669	CEO2
#81	AnnotatorNotes T103	[Coeficiente de extracción de oxígeno]
R95	Before Arg1:T37 Arg2:T85	
R96	Before Arg1:T37 Arg2:T78	
R97	Used_for Arg1:T5 Arg2:T6	
R98	Used_for Arg1:T4 Arg2:T6	
T104	Quantifier_or_Qualifier 1915 1920	grave
#82	AnnotatorNotes T104	C1547227; Severe - Severity of Illness Code; Intellectual Product
R101	Has_Quantifier_or_Qualifier Arg1:T54 Arg2:T104	
R102	Has_Quantifier_or_Qualifier Arg1:T41 Arg2:T104	
T105	CONC 1875 1886	etapa aguda
#83	AnnotatorNotes T105	C0439557; Acute phase; Temporal Concept
R103	Overlap Arg1:T41 Arg2:T105	
R104	Overlap Arg1:T54 Arg2:T105	
R40	Negation Arg1:T75 Arg2:T95	
T106	Quantifier_or_Qualifier 1597 1611	significativas
A8	Assertion T106 Negated
#84	AnnotatorNotes T106	C0750502; Significant; Idea or Concept
R41	Has_Quantifier_or_Qualifier Arg1:T73 Arg2:T106	
R42	Negation Arg1:T70 Arg2:T106	
A9	Experiencer T56 Patient
A10	Experiencer T57 Patient
A11	Experiencer T60 Patient
A12	Experiencer T61 Patient
A13	Experiencer T68 Patient
A14	Experiencer T80 Patient
R26	Has_Result_or_Value Arg1:T52 Arg2:T98	
R43	Has_Result_or_Value Arg1:T34 Arg2:T97	
